NINA VIRA: Open Payments
NPI 1407437379 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 61 payments from 8 companies in 2025. Trend: 2023 $857 · 2024 $1,107 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 27 | $338 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $298 |
| Forte Bio-Pharma LLC | 4 | $69 |
| Valinor Pharma, LLC | 4 | $63 |
| SPR Therapeutics, Inc | 2 | $40 |
| SCILEX PHARMACEUTICALS INC. | 1 | $16 |
| PROTEGA PHARMACEUTIALS INC | 1 | $16 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: RELISTOR, Belbuca, XTAMPZA, PROLATE, MOVANTIK, SPRINT PNS System, ZTLido, ROXYBOND.
Industry payments across NJ — which companies pay providers there.
